Glaukos
GKOS • NYSE
Glaukos is a medical - devices company in the healthcare sector trading on NYSE, led by CEO Thomas William Burns, with a market cap of $6.0B.
CEOThomas William Burns
Next Earnings
Upcoming earnings announcement for Glaukos
Date
Wednesday, April 29, 2026 (in 4 weeks)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.28
Revenue Estimate
$136.0M
Earnings History
Past 12 earnings reports for Glaukos
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | Q4 2025 | -$0.28Est: -$0.21 | -33.3% | $143.1MEst: $137.9M | +3.8% | — |
| Oct 29, 2025 | Q3 2025 | -$0.16Est: -$0.26 | +38.5% | $133.5MEst: $122.3M | +9.2% |  10-Q |
| Jul 30, 2025 | Q2 2025 | -$0.24Est: -$0.26 | +7.7% | $124.1MEst: $115.2M | +7.7% | 10-Q |
| Apr 30, 2025 | Q1 2025 | -$0.22Est: -$0.35 | +37.1% | $106.7MEst: $102.8M | +3.8% | 10-Q |
| Feb 20, 2025 | Q4 2024 | -$0.40Est: -$0.39 | -2.6% | $105.5MEst: $101.0M | +4.5% | 10-K |
| Nov 4, 2024 | Q3 2024 | -$0.28Est: -$0.48 | +41.7% | $96.7MEst: $91.5M | +5.7% | 10-Q |
| Jul 31, 2024 | Q2 2024 | -$0.52Est: -$0.51 | -2.0% | $95.7MEst: $88.9M | +7.6% | 10-Q |
| May 1, 2024 | Q1 2024 | -$0.70Est: -$0.57 | -22.8% | $85.6MEst: $79.6M | +7.6% | 10-Q |
| Feb 21, 2024 | Q4 2023 | -$0.63Est: -$0.55 | -14.5% | $82.4MEst: $78.7M | +4.7% | 10-K |
| Nov 1, 2023 | Q3 2023 | -$0.50Est: -$0.55 | +9.1% | $78.0MEst: $75.3M | +3.7% | — |
| Aug 2, 2023 | Q2 2023 | -$0.55Est: -$0.57 | +3.5% | $80.4MEst: $74.5M | +8.0% | 10-Q |
| May 3, 2023 | Q1 2023 | -$0.59Est: -$0.57 | -3.5% | $73.9MEst: $67.7M | +9.1% | 10-Q |